Aia Group LTD Gilead Sciences, Inc. Transaction History

Aia Group LTD

$3.28 Billion
Q2 2024

A detailed history of Aia Group LTD transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Aia Group LTD holds 23,810 shares of GILD stock, worth $2.1 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

23,810

Previous 22,996 3.54%

Holding current value

$2.1 Million

Previous $1.68 Million 3.03%

% of portfolio

0.05%

Previous 0.06%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$63.15 - $72.88 $51,404 - $59,324	814 Added 3.54%	23,810 $1.63 Million
Q1 2024 May 06, 2024	BUY	$71.58 - $87.29 $1.65 Million - $2.01 Million	22,996 New	22,996 $1.68 Million
Q3 2023 Nov 01, 2023	SELL	$73.94 - $80.67 $110,466 - $120,520	-1,494 Reduced 7.58%	18,206 $1.36 Million
Q2 2023 Jul 28, 2023	SELL	$76.01 - $86.7 $38,385 - $43,783	-505 Reduced 2.5%	19,700 $1.52 Million
Q1 2023 Apr 28, 2023	SELL	$77.31 - $88.08 $229,688 - $261,685	-2,971 Reduced 12.82%	20,205 $1.68 Million
Q4 2022 Jan 31, 2023	BUY	$62.32 - $89.47 $478,555 - $687,040	7,679 Added 49.55%	23,176 $1.99 Million
Q3 2022 Nov 04, 2022	SELL	$59.54 - $68.01 $568,607 - $649,495	-9,550 Reduced 38.13%	15,497 $956,000
Q2 2022 Aug 11, 2022	BUY	$57.72 - $65.01 $29,264 - $32,960	507 Added 2.07%	25,047 $1.55 Million
Q1 2022 May 06, 2022	BUY	$57.92 - $72.58 $1.04 Million - $1.31 Million	18,005 Added 275.52%	24,540 $1.46 Million
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $29,066 - $32,990	448 Added 7.36%	6,535 $475,000
Q3 2021 Nov 05, 2021	BUY	$67.69 - $73.03 $412,029 - $444,533	6,087 New	6,087 $425,000
Q2 2021 Aug 03, 2021	SELL	$63.47 - $69.35 $799,468 - $873,532	-12,596 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$60.0 - $68.46 $418,680 - $477,713	6,978 Added 124.21%	12,596 $814,000
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $318,259 - $362,641	5,618 New	5,618 $362,000

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aia Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Aia Group LTD with notifications on news.

Account